PSC Epidemiology and Outcomes in a Population-based Cohort

Feb 17, 2020 | Ethan McConkey, Moderator | @ethanmcconkey | Comments (1)

2020-02-07 Epidemiology image

In a recent paper published in the Journal of Gastroenterology, Bakhshi et al., reported an update on the epidemiology and outcomes of Primary Sclerosing Cholangitis (PSC) in a population-based cohort. The authors found that the incidence (i.e., the occurrence of new cases per year) of PSC almost doubled from 2001 to 2017 compared to the period from 1976 to 2000. Importantly, patients with PSC were increasingly being diagnosed with milder disease. The intra-individual variation of serum alkaline phosphatase was high, thus,  questioning the use of this biochemical marker as an endpoint in clinical trials.

Read the paper from Dr. Bakhshi

Join others discussing PSC

Interested in more newsfeed posts like this? Go to the Primary Sclerosing Cholangitis (PSC) blog.

I was not part of this research because of not being a resident in Olmstead County. However, I did get my transplant for PSC at Mayo Rochester, after being sent there by my local providers to meet with the experts. I enjoy reading about the research related to PSC, and I feel good knowing that my own experience and records are part of other and ongoing research at Mayo.

Please sign in or register to post a reply.